Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in obese hypertensive patients
NCT00289887Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Losartan Arm with Placebo Arm (2 arms). Primary endpoints: Mean Change From Baseline in Trough Sitting Systolic Blood Pressure (SiSBP) at Week 8, Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP) at Week 8 and 4 more. Started Feb 2006; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00289887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289887.